PubMed
Nucleotide
Protein
Genome
Structure
PopSet
Taxonomy
OMIM
OMIM Update List for July, 2003
Please send your questions to the
NCBI Help Desk
.
July 31, 2003
New Entries:
607998
CLN2 GENE; CLN2
608002
NEPHROCYSTIN 3; NPHP3
608004
INTERLEUKIN 1-INDUCED NUCLEAR ANKYRIN REPEAT PROTEIN
608005
SIL1, S. CEREVISIAE, HOMOLOG OF
608006
LEIOMODIN 2; LMOD2
Changed Entries:
107770
LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 1; LRP1
110600
ADP-RIBOSYLTRANSFERASE 4; ART4
116897
CCAAT/ENHANCER-BINDING PROTEIN, ALPHA; CEBPA
118220
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A; CMT1A
118910
CHROMOGRANIN A; CHGA
154400
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1
159555
MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA; MLL
162350
CEROID LIPOFUSCINOSIS, NEURONAL, DOMINANT OR PARRY TYPE
163950
NOONAN SYNDROME 1; NS1
164761
RET PROTOONCOGENE; RET
165020
V-ROS AVIAN UR2 SARCOMA VIRUS ONCOGENE HOMOLOG 1; ROS1
165240
GLI-KRUPPEL FAMILY MEMBER 3; GLI3
174763
POLYMERASE, DNA, GAMMA; POLG
176860
PROTEIN C DEFICIENCY, CONGENITAL THROMBOTIC DISEASE DUE TO
191045
TROPONIN T2, CARDIAC; TNNT2
191175
TUMOR REJECTION ANTIGEN 1; TRA1
204300
CEROID LIPOFUSCINOSIS, NEURONAL 4; CLN4
204500
CEROID LIPOFUSCINOSIS, NEURONAL 2, LATE INFANTILE; CLN2
204600
MOVED TO 204500
243305
INVERSIN; INVS
256730
CEROID LIPOFUSCINOSIS, NEURONAL 1, INFANTILE; CLN1
263200
POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL RECESSIVE; ARPKD
268100
ENHANCED S-CONE SYNDROME; ESCS
277300
SPONDYLOCOSTAL DYSOSTOSIS, AUTOSOMAL RECESSIVE, 1
300032
ATR-X GENE; ATRX
300221
HODGKIN DISEASE, X-LINKED PSEUDOAUTOSOMAL
301500
FABRY DISEASE
306900
HEMOPHILIA B; HEMB
600722
PALMITOYL-PROTEIN THIOESTERASE 1; PPT1
601441
DIACYLGLYCEROL KINASE, ZETA, 104-KD: DGKZ
601464
LYMPHOID NUCLEAR PROTEIN RELATED TO AF4; LAF4
601780
CEROID LIPOFUSCINOSIS, NEURONAL, LATE INFANTILE, VARIANT
602088
NEPHRONOPHTHISIS 2; NPHP2
602260
PERIOD, DROSOPHILA, HOMOLOG OF; PER1
602634
DNAJ, E. COLI, HOMOLOG OF, SUBFAMILY B, MEMBER 9; DNAJB9
602768
DELTA-LIKE 3; DLL3
604387
NEPHRONOPHTHISIS 3; NPHP3
604712
RIBONUCLEOTIDE REDUCTASE, M2 B; RRM2B
605537
ACTIVATING TRANSCRIPTION FACTOR 6; ATF6
607596
PONTOCEREBELLAR HYPOPLASIA, TYPE I
607685
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC
608002
NEPHROCYSTIN 3; NPHP3
July 30, 2003
New Entries:
607999
ASH1, DROSOPHILA, HOMOLOG OF
608000
N-ACETYLTRANSFERASE 1, S. CEREVISIAE, HOMOLOG OF
608001
MELANOMA INHIBITORY ACTIVITY PROTEIN 2
608003
HOMEODOMAIN-INTERACTING PROTEIN KINASE 1
Changed Entries:
109690
BETA-2-ADRENERGIC RECEPTOR; ADRB2
126110
ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; ARNT
141850
HEMOGLOBIN--ALPHA LOCUS 2; HBA2
141900
HEMOGLOBIN--BETA LOCUS; HBB
143100
HUNTINGTON DISEASE; HD
153670
BERNARD-SOULIER SYNDROME, BENIGN AUTOSOMAL DOMINANT
154790
PROTEASE INHIBITOR 5; PI5
165640
ORNITHINE DECARBOXYLASE 1; ODC1
180750
ROBINOW-SORAUF SYNDROME
204200
CEROID LIPOFUSCINOSIS, NEURONAL 3, JUVENILE; CLN3
300334
TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 5;
313700
ANDROGEN RECEPTOR; AR
600035
EMPTY SPIRACLES, DROSOPHILA, 2, HOMOLOG OF; EMX2
600483
FIBROBLAST GROWTH FACTOR 8; FGF8
600621
STATHMIN-LIKE 2; STMN2
600778
CYCLIN-DEPENDENT KINASE INHIBITOR 1B; CDKN1B
600871
GROWTH FACTOR-INDEPENDENT 1; GFI1
600927
CYCLIN-DEPENDENT KINASE INHIBITOR 2D; CDKN2D
601340
MELANOMA INHIBITORY ACTIVITY PROTEIN; MIA
601622
TWIST, DROSOPHILA, HOMOLOG OF; TWIST
601665
OBESITY
601691
ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 4; ABCA4
601693
UNCOUPLING PROTEIN 2; UCP2
601945
SPLICING FACTOR, ARGININE/SERINE-RICH, 8; SFRS8
602711
FE65-LIKE 2
602952
WOLF-HIRSCHHORN SYNDROME CANDIDATE 1; WHSC1
603745
SLIT, DROSOPHILA, HOMOLOG OF, 3; SLIT3
604619
LEUCINE-RICH GENE, GLIOMA-INACTIVATED, 1; LGI1
605874
POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 9; KCNK9
605974
SLU7, S. CEREVISIAE, HOMOLOG OF
606104
TUBULOPATHY, ENCEPHALOPATHY, AND LIVER FAILURE DUE TO COMPLEX III
607155
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2I; LGMD2I
607765
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 4; PFIC4
607785
JUVENILE MYELOMONOCYTIC LEUKEMIA; JMML
July 29, 2003
New Entries:
607989
SPARC/OSTEONECTIN, CWCV, AND KAZAL-LIKE DOMAINS PROTEOGLYCAN 3; SPOCK3
607992
SPLICING FACTOR 4; SF4
607993
SPLICING FACTOR, ARGININE/SERINE-RICH, 14; SFRS14
607994
STRAND EXCHANGE PROTEIN 1
607995
UNC93, C. ELEGANS, HOMOLOG OF, A; UNC93A
607996
PREPRONEUROPEPTIDE B
607997
PREPRONEUROPEPTIDE W
Changed Entries:
126450
DOPAMINE RECEPTOR D2; DRD2
131100
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I; MEN1
138040
GLUCOCORTICOID RECEPTOR; GCCR
174000
MEDULLARY CYSTIC KIDNEY DISEASE 1; MCKD1
182120
SECRETED PROTEIN, ACIDIC, CYSTEINE-RICH; SPARC
182305
SOLUTE CARRIER FAMILY 8 (SODIUM-CALCIUM EXCHANGER), MEMBER 1; SLC8A1
235200
HEMOCHROMATOSIS; HFE
236750
HYDROPS FETALIS, IDIOPATHIC
309550
FRAGILE SITE MENTAL RETARDATION 1 GENE; FMR1
600730
G PROTEIN-COUPLED RECEPTOR 7; GPR7
600731
G PROTEIN-COUPLED RECEPTOR 8; GPR8
601652
MYOCILIN; MYOC
601795
MITOGEN-ACTIVATED PROTEIN KINASE 3; MAPK3
601901
SOLUTE CARRIER FAMILY 8 (SODIUM-CALCIUM EXCHANGER), MEMBER 2; SLC8A2
602642
TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 11; TNFSF11
603054
CYSTEINE KNOT SUPERFAMILY 1, BMP ANTAGONIST 1; CKTSF1B1
603353
SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER
603860
MEDULLARY CYSTIC KIDNEY DISEASE 2; MCKD2
604517
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA, COACTIVATOR 1; PPARGC1
604698
A-KINASE ANCHOR PROTEIN 12; AKAP12
604860
MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION GENE 1; MALT1
604895
T-BOX 21; TBX21
605066
TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN,
605980
CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 4; CARD4
606272
CYSTINOSIN; CTNS
606359
WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 3A; WNT3A
606463
GLUCOSIDASE, ACID BETA; GBA
606478
PROTECTION OF TELOMERES 1
606665
OPSIN 4; OPN4
606885
ACYL-CoA DEHYDROGENASE, SHORT-CHAIN; ACADS
607008
ACYL-CoA DEHYDROGENASE, MEDIUM-CHAIN; ACADM
607281
LSM1 PROTEIN
607282
LSM2 PROTEIN
607283
LSM3 PROTEIN
607284
LSM4 PROTEIN
607285
LSM5 PROTEIN
607286
LSM6 PROTEIN
607287
LSM7 PROTEIN
607847
NEUTROPENIA, NONIMMUNE CHRONIC IDIOPATHIC, OF ADULTS
607904
CALCIUM CHANNEL, VOLTAGE-DEPENDENT, T TYPE, ALPHA-1H SUBUNIT; CACNA1H
607925
B- AND T-LYMPHOCYTE ATTENUATOR
607941
ATRIAL SEPTAL DEFECT 2; ASD2
July 28, 2003
New Entries:
607986
S100 CALCIUM-BINDING PROTEIN A14; S100A14
607987
ENDOPLASMIC RETICULUM RESIDENT PROTEIN ERDJ5
607988
SPARC/OSTEONECTIN, CWCV, AND KAZAL-LIKE DOMAINS PROTEOGLYCAN 2; SPOCK2
607990
UBIQUITIN-LIKE PROTEIN CONTAINING PHD AND RING FINGER DOMAINS 1; UHRF1
607991
SOLUTE CARRIER FAMILY 8 (SODIUM-CALCIUM EXCHANGER), MEMBER 3; SLC8A3
Changed Entries:
103320
AGRIN; AGRN
113505
BRAIN-DERIVED NEUROTROPHIC FACTOR; BDNF
120120
COLLAGEN, TYPE VII, ALPHA-1; COL7A1
120435
COLON CANCER, FAMILIAL NONPOLYPOSIS, TYPE 1
123260
C-REACTIVE PROTEIN, PENTRAXIN-RELATED; CRP
136535
FORMIN; FMN
139250
GROWTH HORMONE 1; GH1
139330
GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-TRANSDUCING ACTIVITY POLYPEPTIDE
141850
HEMOGLOBIN--ALPHA LOCUS 2; HBA2
142993
CEH10 HOMEODOMAIN-CONTAINING HOMOLOG; CHX10
146660
INTERLEUKIN 7; IL7
147100
IgG HEAVY CHAIN LOCUS; IGHG1
147220
IMMUNOGLOBULIN LAMBDA CONSTANT REGION 1; IGLC1
153870
MACULAR DYSTROPHY, CONCENTRIC ANNULAR
155541
MELANOCORTIN 4 RECEPTOR; MC4R
159001
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1B; LGMD1B
164690
V-ABL ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 2; ABL2
165070
FMS-RELATED TYROSINE KINASE 1; FLT1
168461
CYCLIN D1; CCND1
176640
PRION PROTEIN; PRNP
176948
MITOGEN-ACTIVATED PROTEIN KINASE 1; MAPK1
180380
RHODOPSIN; RHO
188070
THROMBOXANE A2 RECEPTOR, PLATELET; TBXA2R
189980
ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1; ABL1
190080
V-MYC AVIAN MYELOCYTOMATOSIS VIRAL ONCOGENE HOMOLOG; MYC
191306
KINASE INSERT DOMAIN RECEPTOR; KDR
192240
VASCULAR ENDOTHELIAL GROWTH FACTOR; VEGF
202700
NEUTROPENIA, SEVERE CONGENITAL; SCN
247200
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS
313700
ANDROGEN RECEPTOR; AR
600035
EMPTY SPIRACLES, DROSOPHILA, 2, HOMOLOG OF; EMX2
600053
CYCLIC NUCLEOTIDE-GATED CHANNEL, ALPHA-3; CNGA3
600076
TENSIN; TNS
600214
ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; AGER
600281
HEPATOCYTE NUCLEAR FACTOR 4-ALPHA; HNF4A
600289
MITOGEN-ACTIVATED PROTEIN KINASE 14; MAPK14
600456
NEUROTROPHIC TYROSINE KINASE, RECEPTOR, TYPE 2; NTRK2
600483
FIBROBLAST GROWTH FACTOR 8; FGF8
600522
PHOSPHOLIPASE A2, GROUP IVA; PLA2G4A
600576
GATA-BINDING PROTEIN 4; GATA4
600871
GROWTH FACTOR-INDEPENDENT 1; GFI1
600951
TELOMERIC REPEAT-BINDING FACTOR 1; TERF1
601121
PLACENTAL GROWTH FACTOR; PGF
601296
MUSCLE, SKELETAL, RECEPTOR TYROSINE KINASE; MUSK
601462
MYASTHENIC SYNDROME, SLOW-CHANNEL CONGENITAL; SCCMS
601620
T-BOX 5; TBX5
601843
SOLUTE CARRIER FAMILY 5 (SODIUM IODIDE SYMPORTER), MEMBER 5; SLC5A5
602023
CHLORIDE CHANNEL, KIDNEY, B; CLCNKB
602024
CHLORIDE CHANNEL, KIDNEY, A; CLCNKA
602264
SPARC/OSTEONECTIN, CWCV, AND KAZAL-LIKE DOMAINS PROTEOGLYCAN; SPOCK
602365
CATHEPSIN C; CTSC
602983
POTASSIUM CHANNEL, CALCIUM-ACTIVATED, INTERMEDIATE/SMALL CONDUCTANCE,
603511
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1D; LGMD1D
603745
SLIT, DROSOPHILA, HOMOLOG OF, 3; SLIT3
607600
EPIDERMOLYSIS BULLOSA DYSTROPHICA WITH SUBCORNEAL CLEAVAGE; EBDSC
Clinical Synopsis for
153870
MACULAR DYSTROPHY, CONCENTRIC ANNULAR
July 25, 2003
New Entries:
607982
SCY1-LIKE 1; SCYL1
607983
NTKL-BINDING PROTEIN 1
607984
SPROUTY, DROSOPHILA, HOMOLOG OF, 4; SPRY4
607985
N-ACETYLGLUCOSAMINE-1-PHOSPHODIESTER ALPHA-N-ACETYLGLUCOSAMINIDASE;
Changed Entries:
125647
DESMOPLAKIN; DSP
126452
DOPAMINE RECEPTOR D4; DRD4
133430
ESTROGEN RECEPTOR 1; ESR1
134600
FANCONI RENOTUBULAR SYNDROME
135600
FIBRONECTIN 1; FN1
147562
INTERFERON, ALPHA-2; IFNA2
147640
INTERFERON, BETA-1; IFNB1
147660
INTERFERON, ALPHA-1; IFNA1
148043
KERATIN 3; KRT3
173470
INTEGRIN, BETA-3; ITGB3
179505
RAS HOMOLOG GENE FAMILY, MEMBER G; ARHG
182139
5-@HYDROXYTRYPTAMINE RECEPTOR 3A; HTR3A
186745
TALIN 1; TLN1
191170
TUMOR PROTEIN p53; TP53
193210
INTEGRIN, ALPHA-V; ITGAV
305450
FG SYNDROME; FGS1
309850
MONOAMINE OXIDASE A; MAOA
600823
PROTEASE, SERINE, 8; PRSS8
601130
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9
601277
ICHTHYOSIS, LAMELLAR, 2; LI2
601403
DEDICATOR OF CYTOKINESIS 1; DOCK1
601545
PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE, ISOFORM 1B, ALPHA SUBUNIT;
601952
KERATOSIS LINEARIS WITH ICHTHYOSIS CONGENITA AND SCLEROSING KERATODERMA
602048
RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 1; RAC1
604654
5-@HYDROXYTRYPTAMINE RECEPTOR 3B; HTR3B
605875
WISKOTT-ALDRICH SYNDROME PROTEIN FAMILY, MEMBER 2; WASF2
606127
MYOCARDIN
606421
ENGULFMENT AND CELL MOTILITY GENE 2; ELMO2
606545
ICHTHYOSIS, LAMELLAR, 5
606807
SEF, ZEBRAFISH, HOMOLOG OF
July 24, 2003
New Entries:
607973
NEUROPILIN- AND TOLLOID-LIKE 1; NETO1
607974
NEUROPILIN- AND TOLLOID-LIKE 2; NETO2
607978
SAM DOMAIN, SH3 DOMAIN, AND NUCLEAR LOCALIZATION SIGNALS 1; SAMSN1
607979
SERINE HYDROLASE-LIKE; SERHL
607980
TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 7, YEAST, HOMOLOG OF
607981
NEDD8 ULTIMATE BUSTER 1
Changed Entries:
104300
ALZHEIMER DISEASE; AD
104760
AMYLOID BETA A4 PRECURSOR PROTEIN; APP
124030
CYTOCHROME P450, SUBFAMILY IID; CYP2D
124060
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2; CYP1A2
134920
FIBROBLAST GROWTH FACTOR 2; FGF2
138720
GLYCOPROTEIN Ib, PLATELET, BETA POLYPEPTIDE; GP1BB
146680
INSULIN-DEGRADING ENZYME; IDE
147450
SUPEROXIDE DISMUTASE 1; SOD1
147590
MOVED TO 109120
158105
SMALL INDUCIBLE CYTOKINE A2; SCYA2
164760
V-RAF-1 MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1; RAF1
164761
RET PROTOONCOGENE; RET
165640
ORNITHINE DECARBOXYLASE 1; ODC1
173511
GLYCOPROTEIN V, PLATELET; GP5
175100
ADENOMATOUS POLYPOSIS OF THE COLON; APC
176730
INSULIN; INS
180260
RETINOL-BINDING PROTEIN 1; RBP1
192240
VASCULAR ENDOTHELIAL GROWTH FACTOR; VEGF
219750
CYSTINOSIS, ADULT NONNEPHROPATHIC
231200
GIANT PLATELET SYNDROME
300079
BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 4; BIRC4
300130
INTERLEUKIN 13 RECEPTOR, ALPHA-2; IL13RA2
480000
SEX-DETERMINING REGION Y; SRY
590035
TRANSFER RNA, MITOCHONDRIAL, GLYCINE; MTTG
600632
OPIOID-BINDING PROTEIN/CELL ADHESION MOLECULE-LIKE; OPCML
600692
TROPONIN T3, FAST SKELETAL; TNNT3
601007
LEPTIN RECEPTOR; LEPR
601267
CHEMOKINE, CC MOTIF, RECEPTOR 2; CCR2
604285
ALANINE-GLYOXYLATE AMINOTRANSFERASE; AGXT
604370
OVARIAN CANCER, EPITHELIAL
606672
GLYCOPROTEIN Ib, PLATELET, ALPHA POLYPEPTIDE; GP1BA
607047
MJD GENE; MJD
607202
GLUTEN-SENSITIVE ENTEROPATHY, SUSCEPTIBILITY TO
607690
SAR1A, S. CEREVISIAE, HOMOLOG 2; SARA2
607971
TRANSPORTER V7-3, RAT, HOMOLOG OF
607973
NEUROPILIN- AND TOLLOID-LIKE 1; NETO1
607974
NEUROPILIN- AND TOLLOID-LIKE 2; NETO2
Clinical Synopsis for
147590
MOVED TO 109120
July 23, 2003
New Entries:
607965
SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 1;
607966
SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 2;
607967
SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 3;
607969
CDC-LIKE KINASE 4; CLK4
607970
G PROTEIN-COUPLED RECEPTOR 135
607971
TRANSPORTER V7-3, RAT, HOMOLOG OF;;
607972
NEUROTRANSMITTER TRANSPORTER 5
607975
PREGNANCY-INDUCED GROWTH INHIBITOR OKL38
607976
CYTOCHROME c OXIDASE, SUBUNIT IV, ISOFORM 2; COX4I2
607977
HEADCASE, DROSOPHILA, HOMOLOG OF; HECA
Changed Entries:
102520
ACRORENAL SYNDROME
125480
MAJOR AFFECTIVE DISORDER 1; MAFD1
134920
FIBROBLAST GROWTH FACTOR 2; FGF2
152700
LUPUS ERYTHEMATOSUS, SYSTEMIC; SLE
154790
PROTEASE INHIBITOR 5; PI5
160900
DYSTROPHIA MYOTONICA 1
181500
SCHIZOPHRENIA; SCZD
194050
WILLIAMS-BEUREN SYNDROME; WBS
212750
CELIAC DISEASE; CD
235730
HIRSCHSPRUNG DISEASE SYNDROME
271640
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY; SEMDJL
300386
TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 5; TNFSF5
308940
LEIOMYOMATOSIS, ESOPHAGEAL AND VULVAL, WITH NEPHROPATHY
309520
MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS
600170
AQUAPORIN 3; AQP3
602754
POTASSIUM CHANNEL, CALCIUM-ACTIVATED, INTERMEDIATE/SMALL CONDUCTANCE,
607356
EUKARYOTIC TRANSLATION INITIATION FACTOR 2C, SUBUNIT 4; EIF2C4
607685
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC
607686
FIP1-LIKE 1; FIP1L1
607965
SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 1;
607966
SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 2;
607967
SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 3;
July 22, 2003
New Entries:
607963
METHYL-CpG BINDING DOMAIN PROTEIN 3-LIKE 1; MBD3L1
607964
METHYL-CpG BINDING DOMAIN PROTEIN 3-LIKE 2; MBD3L2
607968
PARATHYROID HORMONE-RESPONSIVE B1 GENE
Changed Entries:
109120
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE
190196
TRANSGLUTAMINASE 2; TGM2
200350
ACETYL-CoA CARBOXYLASE-ALPHA; ACACA
301500
FABRY DISEASE
600859
JTV1 GENE
601583
WILMS TUMOR SUPPRESSOR LOCUS
601763
CASPASE 8, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP8
601835
CHEMOKINE, CC MOTIF, RECEPTOR 6; CCR6
605163
G PROTEIN-COUPLED RECEPTOR STRL33
605209
CHECKPOINT PROTEIN WITH FHA AND RING FINGER DOMAINS; CHFR
605386
LET7, C. ELEGANS, HOMOLOG OF, A1
605715
B7 HOMOLOG 3
605874
POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 9; KCNK9
July 21, 2003
New Entries:
607960
DEAD/H BOX 32; DDX32
607961
SEMAPHORIN 7A; SEMA7A
607962
MICRO RNA 23
Changed Entries:
107400
PROTEASE INHIBITOR 1; PI
107720
APOLIPOPROTEIN C-III; APOC3
116790
CATECHOL-O-METHYLTRANSFERASE; COMT
123810
cAMP RESPONSE ELEMENT-BINDING PROTEIN 1; CREB1
139605
HAIRY AND ENHANCER OF SPLIT 1, DROSOPHILA, HOMOLOG OF; HES1
162060
GROWTH ASSOCIATED PROTEIN 43; GAP43
181500
SCHIZOPHRENIA; SCZD
248370
MANDIBULOACRAL DYSPLASIA; MAD
249100
FAMILIAL MEDITERRANEAN FEVER; FMF
256000
LEIGH SYNDROME; LS
301500
FABRY DISEASE
606368
APOLIPOPROTEIN A-V; APOA5
606673
BETA-UREIDOPROPIONASE; UPB1
607093
5,10-@METHYLENETETRAHYDROFOLATE REDUCTASE; MTHFR
607857
PSORIASIS SUSCEPTIBILITY 9
July 18, 2003
New Entries:
300444
SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER), MEMBER 14;
607955
STERILE ALPHA MOTIFS- AND SH3 DOMAIN-CONTAINING PROTEIN 1;
607956
MEDIATOR OF RNA POLYMERASE II TRANSCRIPTION, SUBUNIT 8, S. CEREVISIAE,
607957
CAMK1-LIKE PROTEIN KINASE
607958
SYNTAXIN-BINDING PROTEIN 6; STXBP6
607959
SOLUTE CARRIER FAMILY 7, MEMBER 10; SLC7A10
Changed Entries:
139250
GROWTH HORMONE 1; GH1
162200
NEUROFIBROMATOSIS, TYPE I; NF1
191330
UBIQUINOL-CYTOCHROME c REDUCTASE-BINDING PROTEIN; UQCRB
253000
MUCOPOLYSACCHARIDOSIS TYPE IVA
600725
SONIC HEDGEHOG; SHH
602984
MEDIATOR OF RNA POLYMERASE II TRANSCRIPTION, SUBUNIT 6, S. CEREVISIAE,
July 17, 2003
New Entries:
300443
SOLUTE CARRIER FAMILY 7, MEMBER 3; SLC7A3
607952
SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, GABA), MEMBER
607953
NEURONAL PROTEIN, 25-KD, RAT, HOMOLOG OF
607954
RAN GUANINE NUCLEOTIDE RELEASE FACTOR
Changed Entries:
107910
CYTOCHROME P450, FAMILY 19, SUBFAMILY A, POLYPEPTIDE 1; CYP19A1
122470
CORNELIA DE LANGE SYNDROME 1; CDL1
130020
EHLERS-DANLOS SYNDROME, TYPE III
130080
EHLERS-DANLOS SYNDROME, TYPE VIII
136850
FUMARATE HYDRATASE; FH
137580
GILLES DE LA TOURETTE SYNDROME; GTS
139250
GROWTH HORMONE 1; GH1
143100
HUNTINGTON DISEASE; HD
151410
BREAKPOINT CLUSTER REGION; BCR
176948
MITOGEN-ACTIVATED PROTEIN KINASE 1; MAPK1
179050
PYRUVATE KINASE 3; PK3
188555
MOVED TO 179050
600289
MITOGEN-ACTIVATED PROTEIN KINASE 14; MAPK14
600532
NADH-UBIQUINONE OXIDOREDUCTASE FLAVOPROTEIN 2; NDUFV2
600692
TROPONIN T3, FAST SKELETAL; TNNT3
600985
TENASCIN-XB; TNXB
601680
ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, TYPE 2B; AMCD2B
601795
MITOGEN-ACTIVATED PROTEIN KINASE 3; MAPK3
602985
NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 2; NDUFS2
603506
LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 5; LRP5
604634
TRANSGELIN 2; TAGLN2
July 16, 2003
New Entries:
607950
TESTIS-SPECIFIC PROTEASE 50
607951
TRANSLOKIN
Clinical Synopsis for
604377
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE
Changed Entries:
131960
EPIDERMOLYSIS BULLOSA SIMPLEX WITH MOTTLED PIGMENTATION; EBS-MP
143450
HYDROXYACYL-CoA DEHYDROGENASE/3-KETOACYL-CoA THIOLASE/ENOYL-CoA HYDRATASE,
173650
KINDLER SYNDROME
182389
SODIUM CHANNEL, NEURONAL TYPE I, ALPHA SUBUNIT; SCN1A
253250
MULIBREY NANISM
300377
DYSTROPHIN; DMD
600289
MITOGEN-ACTIVATED PROTEIN KINASE 14; MAPK14
600480
TRANSCRIPTION FACTOR 12; TCF12
601029
MESODERM-SPECIFIC TRANSCRIPT, MOUSE, HOMOLOG OF; MEST
605073
TRIPARTITE MOTIF-CONTAINING PROTEIN 37; TRIM37
606066
LIM HOMEO BOX GENE 9; LHX9
606201
WOLFRAM SYNDROME GENE 1; WFS1
607746
PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY C, MEMBER 1;
607900
KINDLIN 1
607901
UNC112-RELATED PROTEIN 2
Clinical Synopsis for
162350
CEROID LIPOFUSCINOSIS, NEURONAL, DOMINANT OR PARRY TYPE
Clinical Synopsis for
204200
CEROID LIPOFUSCINOSIS, NEURONAL 3, JUVENILE; CLN3
Clinical Synopsis for
204300
CEROID LIPOFUSCINOSIS, NEURONAL 4; CLN4
Clinical Synopsis for
204500
CEROID LIPOFUSCINOSIS, NEURONAL 2, LATE INFANTILE TYPE; CLN2
Clinical Synopsis for
256730
CEROID LIPOFUSCINOSIS, NEURONAL 1, INFANTILE; CLN1
Clinical Synopsis for
600143
CEROID LIPOFUSCINOSIS, NEURONAL 8; CLN8
Clinical Synopsis for
600680
CEROID LIPOFUSCINOSIS, JUVENILE NEURONAL, WITH GRANULAR OSMIOPHILIC
Clinical Synopsis for
601780
CEROID LIPOFUSCINOSIS, NEURONAL, LATE-INFANTILE, VARIANT
July 15, 2003
New Entries:
607947
POTASSIUM CHANNEL REGULATOR; KCNRG
Changed Entries:
100690
CHOLINERGIC RECEPTOR, NICOTINIC, ALPHA POLYPEPTIDE 1; CHRNA1
100710
CHOLINERGIC RECEPTOR, NICOTINIC, BETA POLYPEPTIDE 1; CHRNB1
100720
CHOLINERGIC RECEPTOR, NICOTINIC, DELTA POLYPEPTIDE; CHRND
100725
CHOLINERGIC RECEPTOR, NICOTINIC, EPSILON POLYPEPTIDE; CHRNE
100730
CHOLINERGIC RECEPTOR, NICOTINIC, GAMMA POLYPEPTIDE; CHRNG
102720
DIPEPTIDYL PEPTIDASE IV; DPP4
116790
CATECHOL-O-METHYLTRANSFERASE; COMT
133170
ERYTHROPOIETIN; EPO
136140
FLOATING-HARBOR SYNDROME
139393
GUILLAIN-BARRE SYNDROME, FAMILIAL
147200
IMMUNOGLOBULIN KAPPA CONSTANT REGION; IGKC
150250
LARSEN SYNDROME, AUTOSOMAL DOMINANT; LRS1
162000
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE; HNFJ
176270
PRADER-WILLI SYNDROME; PWS
176920
PROTEUS SYNDROME
191845
UROMODULIN; UMOD
210250
SITOSTEROLEMIA
213700
CEREBROTENDINOUS XANTHOMATOSIS
243800
JOHANSON-BLIZZARD SYNDROME; JBS
252150
MOLYBDENUM COFACTOR DEFICIENCY
266600
INFLAMMATORY BOWEL DISEASE 1; IBD1
314300
TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR
600950
ARYLALKYLAMINE N-ACETYLTRANSFERASE; AANAT
600953
INTERLEUKIN 18; IL18
601349
MICROCEPHALY, MICROPHTHALMIA, ECTRODACTYLY OF LOWER LIMBS, AND PROGNATHISM;
601487
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA; PPARG
601620
T-BOX 5; TBX5
601728
PHOSPHATASE AND TENSIN HOMOLOG; PTEN
601837
LIGASE IV, DNA, ATP-DEPENDENT; LIG4
603680
SPINOCEREBELLAR ATAXIA 8; SCA8
603707
MOLYBDENUM COFACTOR SYNTHESIS 1; MOCS1
603860
MEDULLARY CYSTIC KIDNEY DISEASE 2; MCKD2
603930
GEPHYRIN; GPH
603961
SEMAPHORIN 3A; SEMA3A
604113
INTERLEUKIN 18-BINDING PROTEIN; IL18BP
605597
FORKHEAD TRANSCRIPTION FACTOR FOXL2; FOXL2
605930
SORTING NEXIN 3; SNX3
607544
LEUCINE-RICH PPR MOTIF-CONTAINING PROTEIN; LRPPRC
607809
ACETYL-CoA ACETYLTRANSFERASE 1; ACAT1
607923
SYNAPTOSOMAL-ASSOCIATED PROTEIN, 91-KD; SNAP91
Clinical Synopsis for
176920
PROTEUS SYNDROME
July 15, 2003
New Entries:
607945
ADIPONECTIN RECEPTOR 1
607946
ADIPONECTIN RECEPTOR 2
Changed Entries:
116900
CDC28 PROTEIN KINASE 1B; CKS1B
120470
DELETED IN COLORECTAL CARCINOMA; DCC
125853
DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM
138040
GLUCOCORTICOID RECEPTOR; GCCR
142858
MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DP BETA-1; HLA-DPB1
147450
SUPEROXIDE DISMUTASE 1; SOD1
174000
MEDULLARY CYSTIC KIDNEY DISEASE 1; MCKD1
238970
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME
263570
POLYGLUCOSAN BODY DISEASE, ADULT FORM; APBD
600163
SODIUM CHANNEL, VOLTAGE-GATED, TYPE V, ALPHA SUBUNIT; SCN5A
601614
NETRIN 1, MOUSE, HOMOLOG OF; NTN1
602421
CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR
602544
PARKIN; PARK2
603134
CULLIN 1; CUL1
603610
UNC5, C. ELEGANS, HOMOLOG OF, C; UNC5C
603618
CELL DIVISION CYCLE 20, S. CEREVISIAE, HOMOLOG OF; CDC20
603860
MEDULLARY CYSTIC KIDNEY DISEASE 2; MCKD2
603861
SOLUTE CARRIER FAMILY 25, MEMBER 15; SLC25A15
603887
TIMELESS, DROSOPHILA, HOMOLOG OF; TIMELESS
606168
DEAD/H BOX 20; DDX20
606229
EUKARYOTIC TRANSLATION INITIATION FACTOR 2C, SUBUNIT 2; EIF2C2
606278
F-BOX AND WD40 DOMAIN PROTEIN 7; FBXW7
606969
GEM-ASSOCIATED PROTEIN 4; GEMIN4
607839
GLYCOGEN BRANCHING ENZYME; GBE1
July 11, 2003
New Entries:
607944
COMBINED IMMUNODEFICIENCY WITH AUTOIMMUNITY AND SPONDYLOMETAPHYSEAL
Changed Entries:
102200
ACROMEGALY
131195
ENDOGLIN; ENG
139320
GNAS COMPLEX LOCUS; GNAS
163890
SYNUCLEIN, ALPHA; SNCA
241850
HYPOTHYROIDISM, ATHYROIDAL, WITH SPIKY HAIR AND CLEFT PALATE
266600
INFLAMMATORY BOWEL DISEASE 1; IBD1
276900
USHER SYNDROME, TYPE IA; USH1A
300199
RNA-BINDING MOTIF PROTEIN, X CHROMOSOME; RBMX
300258
ROIFMAN SYNDROME
300600
ALBINISM, OCULAR, TYPE II; OA2
301500
FABRY DISEASE
400006
RNA-BINDING MOTIF PROTEIN, Y CHROMOSOME, FAMILY 1, MEMBER A1; RBMY1A1
600609
GA-BINDING PROTEIN TRANSCRIPTION FACTOR, ALPHA SUBUNIT; GABPA
600610
GA-BINDING PROTEIN TRANSCRIPTION FACTOR, BETA SUBUNIT; GABPB
601627
SURVIVAL OF MOTOR NEURON 2, CENTROMERIC; SMN2
602617
FORKHEAD BOX E1; FOXE1
602719
SPLICING FACTOR, ARGININE/SERINE-RICH, 10; SFRS10
604408
MOVED TO 600610
604717
DEAFNESS, AUTOSOMAL DOMINANT 20; DFNA20
605908
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS GENE 1;
606938
UROPORPHYRINOGEN III SYNTHASE; UROS
607145
DYSTROBREVIN-BINDING PROTEIN 1; DTNBP1
Clinical Synopsis for
220111
LEIGH SYNDROME, FRENCH-CANADIAN TYPE; LSFC
Clinical Synopsis for
256000
LEIGH SYNDROME; LS
Clinical Synopsis for
308930
LEIGH SYNDROME, X-LINKED
July 10, 2003
New Entries:
607942
PHOSPHOINOSITIDE 3-KINASE ADAPTOR PROTEIN 1
607943
Ca(2+)-PROMOTED RAS INACTIVATOR
Changed Entries:
104760
AMYLOID BETA A4 PRECURSOR PROTEIN; APP
108800
ATRIAL SEPTAL DEFECT 1; ASD1
109636
BETA-ADRENERGIC RECEPTOR KINASE 2; ADRBK2
114500
COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS; HNPCC
139900
HAND SKILL, RELATIVE; HSR
140580
HEAT-SHOCK TRANSCRIPTION FACTOR 1; HSF1
147620
INTERLEUKIN 6; IL6
147880
INTERLEUKIN 6 RECEPTOR; IL6R
170998
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-ALPHA; PPARA
172420
PHOSPHOLIPASE C, GAMMA-1; PLCG1
173610
SELECTIN P; SELP
176830
PROOPIOMELANOCORTIN; POMC
180435
RIBONUCLEASE L; RNASEL
180902
RYANODINE RECEPTOR 2; RYR2
180903
RYANODINE RECEPTOR 3; RYR3
185620
SURFEIT 1; SURF1
191020
TROPHOBLAST-LYMPHOCYTE CROSSREACTIVE ANTIGEN
192240
VASCULAR ENDOTHELIAL GROWTH FACTOR; VEGF
220110
COMPLEX IV, MITOCHONDRIAL RESPIRATORY CHAIN, DEFICIENCY OF
220111
LEIGH SYNDROME, FRENCH-CANADIAN TYPE; LSFC
221770
PRESENILE DEMENTIA WITH BONE CYSTS
256000
LEIGH SYNDROME; LS
300377
DYSTROPHIN; DMD
306700
HEMOPHILIA A
308930
LEIGH SYNDROME, X-LINKED
312170
PYRUVATE DEHYDROGENASE COMPLEX, E1-ALPHA POLYPEPTIDE 1; PDHA1
516030
COMPLEX IV, CYTOCHROME c OXIDASE SUBUNIT I; MTCO1
600211
RUNT-RELATED TRANSCRIPTION FACTOR 2; RUNX2
600571
RE1-SILENCING TRANSCRIPTION FACTOR; REST
600694
INTERLEUKIN 6 SIGNAL TRANSDUCER; IL6ST
600807
ASTHMA
601409
HIV-1 TAT-INTERACTING PROTEIN; HTATIP
601860
17-@BETA-HYDROXYSTEROID DEHYDROGENASE IV; HSD17B4
602354
LINKER FOR ACTIVATION OF T CELLS; LAT
602709
AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY B, MEMBER 1; APBB1
603273
TUMOR PROTEIN p73-LIKE; TP73L
603324
GAP JUNCTION PROTEIN, BETA-3; GJB3
603644
SCO1, S. CEREVISIAE, HOMOLOG OF; SCO1
603647
BCS1, S. CEREVISIAE, HOMOLOG-LIKE; BCS1L
603962
RAS GUANYL NUCLEOTIDE-RELEASING PROTEIN 1; RASGRP1
604020
BASSOON, MOUSE, HOMOLOG OF; BSN
604377
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE
604610
RECQ PROTEIN-LIKE 3; RECQL3
604906
SCHIZOPHRENIA 9; SCZD9
605086
TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; TREM2
605257
ACTIVATION-INDUCED CYTIDINE DEAMINASE; AICDA
605696
POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY G, MEMBER 2; KCNG2
606266
BCL2-MODIFYING FACTOR
606640
AMYOTROPHIC LATERAL SCLEROSIS 3; ALS3
606829
FRDA GENE; FRDA
606830
ATP/GTP-BINDING PROTEIN 1; AGTPBP1
607116
ALZHEIMER DISEASE 8
607251
TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 22, YEAST, HOMOLOG OF;
607536
MUCOEPIDERMOID CARCINOMA-TRANSLOCATED 1; MECT1
607537
MASTERMIND-LIKE 2; MAML2
607747
MIG2- AND FILAMIN-INTERACTING PROTEIN
607941
ATRIAL SEPTAL DEFECT 2; ASD2
607943
Ca(2+)-PROMOTED RAS INACTIVATOR
Clinical Synopsis for
530000
KEARNS-SAYRE SYNDROME; KSS
July 9, 2003
New Entries:
Clinical Synopsis for
606072
RIPPLING MUSCLE DISEASE; RMD
Changed Entries:
102610
ACTIN, ALPHA, SKELETAL MUSCLE 1; ACTA1
102775
ADENOSINE A1 RECEPTOR; ADORA1
102777
ADENOSINE A2 RECEPTOR-LIKE; ADORA2L1
104300
ALZHEIMER DISEASE; AD
110700
BLOOD GROUP--DUFFY SYSTEM; FY
112203
CD80 ANTIGEN; CD80
121011
GAP JUNCTION PROTEIN, BETA-2; GJB2
121014
GAP JUNCTION PROTEIN, ALPHA-1; GJA1
135600
FIBRONECTIN 1; FN1
147559
INTEGRIN, BETA-7; ITGB7
147620
INTERLEUKIN 6; IL6
147840
INTERCELLULAR ADHESION MOLECULE 1; ICAM1
151445
LEUKOCYTE ANTIGEN CD23; CD23
155541
MELANOCORTIN 4 RECEPTOR; MC4R
160777
MYOSIN VA; MYO5A
162200
NEUROFIBROMATOSIS, TYPE I; NF1
162350
CEROID LIPOFUSCINOSIS, NEURONAL, DOMINANT OR PARRY TYPE
164500
SPINOCEREBELLAR ATAXIA 7; SCA7
173320
RIBONUCLEASE/ANGIOGENIN INHIBITOR; RNH
174763
POLYMERASE, DNA, GAMMA; POLG
182133
5-@HYDROXYTRYPTAMINE RECEPTOR 1D; HTR1D
182390
SODIUM CHANNEL, VOLTAGE-GATED, TYPE II, ALPHA-1 SUBUNIT; SCN2A1
190685
DOWN SYNDROME
191010
TROPOMYOSIN 1; TPM1
191040
TROPONIN C, SLOW; TNNC1
191044
TROPONIN I, CARDIAC; TNNI3
191045
TROPONIN T2, CARDIAC; TNNT2
192321
VASOACTIVE INTESTINAL PEPTIDE RECEPTOR 1; VIPR1
192975
INTEGRIN, ALPHA-4; ITGA4
233700
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL CYTOCHROME-b-POSITIVE FORM
256730
CEROID LIPOFUSCINOSIS, NEURONAL 1, INFANTILE; CLN1
270230
SKELETAL DYSPLASIA, SAN DIEGO TYPE
277900
WILSON DISEASE
300020
MOVED TO 102610
300304
CULLIN 4B; CUL4B
312610
RETINITIS PIGMENTOSA GTPase REGULATOR; RPGR
312750
RETT SYNDROME; RTT
313700
ANDROGEN RECEPTOR; AR
516003
COMPLEX I, SUBUNIT ND4; MTND4
590060
TRANSFER RNA, MITOCHONDRIAL, LYSINE; MTTK
600571
RE1-SILENCING TRANSCRIPTION FACTOR; REST
600621
STATHMIN-LIKE 2; STMN2
600722
PALMITOYL-PROTEIN THIOESTERASE 1; PPT1
601620
T-BOX 5; TBX5
602565
CHEMOKINE, CC MOTIF, LIGAND 25; CCL25
603137
CULLIN 4A; CUL4A
604738
CHEMOKINE, CC MOTIF, RECEPTOR 9; CCR9
605353
GHRELIN
605446
RETINITIS PIGMENTOSA GTPase REGULATOR-INTERACTING PROTEIN; RPGRIP1
605525
DOUBLE PARKED, DROSOPHILA, HOMOLOG OF
605717
B7 HOMOLOG 2
606227
MEMBRANE-TYPE FRIZZLED-RELATED PROTEIN; MFRP
607462
DRPLA GENE; DRPLA
607574
ARYLSULFATASE A; ARSA
Clinical Synopsis for
256700
NEUROBLASTOMA
Clinical Synopsis for
300020
MOVED TO 102610
Clinical Synopsis for
530000
KEARNS-SAYRE SYNDROME; KSS
Clinical Synopsis for
600332
RIPPLING MUSCLE DISEASE 1; RMD1
July 8, 2003
New Entries:
607941
ATRIAL SEPTAL DEFECT
Changed Entries:
103220
SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER), MEMBER 4; SLC25A4
111150
BLOOD GROUP--LUTHERAN INHIBITOR
111400
BLOOD GROUP, P SYSTEM
111410
MOVED TO 111400
124030
CYTOCHROME P450, SUBFAMILY IID; CYP2D
128990
EARLY GROWTH RESPONSE 1; EGR1
132810
EPOXIDE HYDROLASE 1, MICROSOMAL; EPHX1
134921
FIBROBLAST GROWTH FACTOR 6; FGF6
134934
FIBROBLAST GROWTH FACTOR RECEPTOR 3; FGFR3
135150
BIRT-HOGG-DUBE SYNDROME; BHD
151210
THANATOPHORIC DYSPLASIA VARIANTS
164730
V-AKT MURINE THYMOMA VIRAL ONCOGENE HOMOLOG 1; AKT1
164731
V-AKT MURINE THYMOMA VIRAL ONCOGENE HOMOLOG 2; AKT2
164870
V-ERB-B2 AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG 2; ERBB2
165160
V-JUN AVIAN SARCOMA VIRUS 17 ONCOGENE HOMOLOG; JUN
173910
POLYCYSTIC KIDNEY DISEASE 2; PKD2
242900
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE
248450
MANITOBA OCULOTRICHOANAL SYNDROME; MOTA
250800
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE
270230
SKELETAL DYSPLASIA, SAN DIEGO TYPE
300346
HIV-1 TAT STIMULATORY FACTOR 1; HTATSF1
300400
SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED; SCIDX1
309550
FRAGILE SITE MENTAL RETARDATION 1 GENE; FMR1
516040
COMPLEX IV, CYTOCHROME c OXIDASE SUBUNIT II; MTCO2
516050
CYTOCHROME c OXIDASE III; MTCO3
590035
TRANSFER RNA, MITOCHONDRIAL, GLYCINE; MTTG
590045
TRANSFER RNA, MITOCHONDRIAL, ISOLEUCINE; MTTI
600247
ELK3, ETS-DOMAIN PROTEIN; ELK3
600576
GATA-BINDING PROTEIN 4; GATA4
600892
SINGLE-MINDED, DROSOPHILA, HOMOLOG OF, 2; SIM2
601313
POLYCYSTIC KIDNEY DISEASE 1; PKD1
601403
DEDICATOR OF CYTOKINESIS 1; DOCK1
602403
BLEOMYCIN HYDROLASE; BLMH
602506
CYCLIN T1; CCNT1
602896
MITOGEN-ACTIVATED PROTEIN KINASE 9; MAPK9
603094
UDP-GAL:BETA-GlcNAc BETA-1,3-GALACTOSYLTRANSFERASE, POLYPEPTIDE 3;
603251
CYCLIN-DEPENDENT KINASE 9; CDK9
603827
BCL2-LIKE 11; BCL2L11
604616
T-BOX, BRAIN, 1; TBR1
604824
KLOTHO; KL
606170
GENITOPATELLAR SYNDROME
606573
FYN-RELATED KINASE; FRK
606829
FRDA GENE; FRDA
607020
RAS ASSOCIATION DOMAIN FAMILY PROTEIN 5; RASSF5
607273
FOLLICULIN
607845
EXPORTIN 5; XPO5
607922
ALPHA-1,4-GALACTOSYLTRANSFERASE; A4GALT
July 7, 2003
Changed Entries:
103300
AGLOSSIA-ADACTYLIA
105835
ANGEL-SHAPED PHALANGOEPIPHYSEAL DYSPLASIA; ASPED
116960
MORTALITY FACTOR 4; MORF4
120070
COLLAGEN, TYPE IV, ALPHA-3; COL4A3
120350
COLLAGEN, TYPE XIII, ALPHA-1; COL13A1
131340
PRODYNORPHIN; PDYN
132400
EPIPHYSEAL DYSPLASIA, MULTIPLE, 1; EDM1
141200
HEMATURIA, BENIGN FAMILIAL; BFH
150330
LAMIN A/C; LMNA
151626
LINE RETROTRANSPOSABLE ELEMENT 1; LRE1
155541
MELANOCORTIN 4 RECEPTOR; MC4R
176670
HUTCHINSON-GILFORD PROGERIA SYNDROME; HGPS
214500
CHEDIAK-HIGASHI SYNDROME; CHS
231670
GLUTARICACIDEMIA I
252010
COMPLEX I, MITOCHONDRIAL RESPIRATORY CHAIN, DEFICIENCY OF
274000
THROMBOCYTOPENIA--ABSENT RADIUS SYNDROME
306900
HEMOPHILIA B; HEMB
600731
G PROTEIN-COUPLED RECEPTOR 8; GPR8
601243
TOPOISOMERASE, DNA, III, ALPHA; TOP3A
601410
DIABETES MELLITUS, TRANSIENT NEONATAL
601556
ATAXIN 1; ATX1
601665
OBESITY
603788
POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY G, MEMBER 1; KCNG1
604610
RECQ PROTEIN-LIKE 3; RECQL3
604965
SERINE/THREONINE PROTEIN KINASE 4; STK4
606202
MEMBRANE-ASSOCIATED TRANSPORTER PROTEIN; MATP
606594
SET DOMAIN-CONTAINING PROTEIN 7
607020
RAS ASSOCIATION DOMAIN FAMILY PROTEIN 5; RASSF5
July 3, 2003
New Entries:
607939
SULFATASE-MODIFYING FACTOR 1
607940
SULFATASE-MODIFYING FACTOR 2
Changed Entries:
102573
ACTININ, ALPHA-2; ACTN2
120070
COLLAGEN, TYPE IV, ALPHA-3; COL4A3
120435
COLON CANCER, FAMILIAL NONPOLYPOSIS, TYPE 1
141200
HEMATURIA, BENIGN FAMILIAL; BFH
147780
INTERLEUKIN 4; IL4
147781
INTERLEUKIN 4 RECEPTOR; IL4R
156560
METHIONYL-tRNA SYNTHETASE; MARS
212750
CELIAC DISEASE; CD
233450
GOODPASTURE SYNDROME
262300
ACHROMATOPSIA 3; ACHM3
272200
MULTIPLE SULFATASE DEFICIENCY; MSD
300200
ADRENAL HYPOPLASIA, CONGENITAL; AHC
300377
DYSTROPHIN; DMD
600063
AUTOANTIGEN Ro/SSA, 60-KD; RO60
600490
NUCLEAR FACTOR OF ACTIVATED T CELLS, CYTOPLASMIC, CALCINEURIN-DEPENDENT
600859
JTV1 GENE
601556
ATAXIN 1; ATX1
602141
NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 8; NDUFS8
605080
CYCLIC NUCLEOTIDE-GATED CHANNEL, BETA-3; CNGB3
607544
LEUCINE-RICH PPR MOTIF-CONTAINING PROTEIN; LRPPRC
July 2, 2003
New Entries:
607937
HOMEO BOX TRANSCRIPTION FACTOR NANOG
607938
NEUROTRIMIN
Changed Entries:
107741
APOLIPOPROTEIN E; APOE
131240
ENDOTHELIN 1; EDN1
131244
ENDOTHELIN RECEPTOR, TYPE B; EDNRB
180200
RETINOBLASTOMA; RB1
180300
RHEUMATOID ARTHRITIS; RA
516030
COMPLEX IV, CYTOCHROME c OXIDASE SUBUNIT I; MTCO1
590080
TRANSFER RNA, MITOCHONDRIAL, SERINE, 1; MTTS1
600274
FRONTOTEMPORAL DEMENTIA
600490
NUCLEAR FACTOR OF ACTIVATED T CELLS, CYTOPLASMIC, CALCINEURIN-DEPENDENT
600632
OPIOID-BINDING PROTEIN/CELL ADHESION MOLECULE-LIKE; OPCML
601627
SURVIVAL OF MOTOR NEURON 2, CENTROMERIC; SMN2
601850
RETINITIS PIGMENTOSA-DEAFNESS SYNDROME 1, AUTOSOMAL DOMINANT
602698
NUCLEAR FACTOR OF ACTIVATED T CELLS, CYTOPLASMIC, CALCINEURIN-DEPENDENT
602699
NUCLEAR FACTOR OF ACTIVATED T CELLS, CYTOPLASMIC, CALCINEURIN-DEPENDENT
604176
SUPPRESSOR OF CYTOKINE SIGNALING 3
604370
OVARIAN CANCER, EPITHELIAL
607084
DEAFNESS, AUTOSOMAL RECESSIVE 31; DFNB31
607113
APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3G;
607740
UBIQUITIN-SPECIFIC PROTEASE 32; USP32
607928
WHIRLIN; WHRN
July 1, 2003
New Entries:
607934
PEPTIDYLARGININE DEIMINASE, TYPE I; PADI1
607935
PEPTIDYLARGININE DEIMINASE, TYPE II; PADI2
Changed Entries:
180200
RETINOBLASTOMA; RB1
602858
7-@DEHYDROCHOLESTEROL REDUCTASE; DHCR7
603372
THYROID-STIMULATING HORMONE RECEPTOR; TSHR
605347
PEPTIDYLARGININE DEIMINASE, TYPE IV; PADI4
606755
PEPTIDYLARGININE DEIMINASE III; PADI3
Disclaimer
|
Write to the Help Desk
|
Privacy Policy
NCBI
|
NLM
|
NIH